Authors:
KEENAN RM
MILLER WH
KWON C
ALI FE
CALLAHAN JF
CALVO RR
HWANG SM
KOPPLE KD
PEISHOFF CE
SAMANEN JM
WONG AS
YUAN CK
HUFFMAN WF
Citation: Rm. Keenan et al., DISCOVERY OF POTENT NONPEPTIDE VITRONECTIN RECEPTOR (ALPHA(V)BETA(3))ANTAGONISTS, Journal of medicinal chemistry, 40(15), 1997, pp. 2289-2292
Authors:
MILLER WH
ALI FE
BONDINELL WE
CALLAHAN JF
CALVO RR
EGGLESTON DS
HALTIWANGER RC
HUFFMAN WF
HWANG SM
JAKAS DR
KEENAN RM
KOSTER PF
KU TW
KWON C
NEWLANDER KA
NICHOLS AJ
PARKER MF
SAMANEN JM
SOUTHALL LS
TAKATA DT
UZINSKAS IN
VALOCIK RE
VASKOMOSER JA
WONG AS
YELLIN TO
YUAN CCK
Citation: Wh. Miller et al., STRUCTURE-ACTIVITY-RELATIONSHIPS IN 3-OXO-1,4-BENZODIAZEPINE-2-ACETICACID GPIIB IIIA ANTAGONISTS - THE 2-BENZAZEPINE SERIES/, Bioorganic & medicinal chemistry letters, 6(21), 1996, pp. 2481-2486
Citation: Jf. Callahan, FITZGERALD,F.SCOTT EVOLVING AMERICAN-DREAM - THE PURSUIT OF HAPPINESSIN 'GATSBY', 'TENDER IS THE NIGHT', AND THE 'LAST TYCOON', Twentieth century literature, 42(3), 1996, pp. 374-395
Authors:
SAMANEN JM
ALI FE
BARTON LS
BONDINELL WE
BURGESS JL
CALLAHAN JF
CALVO RR
CHEN WT
CHEN LC
ERHARD K
FEUERSTEIN G
HEYS R
HWANG SM
JAKAS DR
KEENAN RM
KU TW
KWON C
LEE CP
MILLER WH
NEWLANDER KA
NICHOLS A
PARKER M
PEISHOFF CE
RHODES G
ROSS S
SHU A
SIMPSON R
TAKATA D
YELLIN TO
UZSINSKAS I
VENSLAVSKY JW
YUAN CK
HUFFMAN WF
Citation: Jm. Samanen et al., POTENT, SELECTIVE, ORALLY-ACTIVE 3-OXO-1,4-BENZODIAZEPINE GPIIB IIIA INTEGRIN ANTAGONISTS/, Journal of medicinal chemistry, 39(25), 1996, pp. 4867-4870
Authors:
BHATNAGAR PK
AGNER EK
ALBERTS D
ARBO BE
CALLAHAN JF
CUTHBERTSON AS
ENGELSEN SJ
FJERDINGSTAD H
HARTMANN M
HEERDING D
HIEBL J
HUFFMAN WF
HYSBEN M
KING AG
KREMMINGER P
KWON C
LOCASTRO S
LOVHAUG D
PELUS LM
PETTEWAY S
TAKATA JS
Citation: Pk. Bhatnagar et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL HEMATOREGULATORY PEPTIDES, Journal of medicinal chemistry, 39(19), 1996, pp. 3814-3819
Authors:
BHATNAGAR PK
ALBERTS D
CALLAHAN JF
HEERDING D
HUFFMAN WF
KING AG
LOCASTRO S
PELUS LM
TAKATA JS
Citation: Pk. Bhatnagar et al., DEVELOPMENT OF A PHARMACOPHORE MODEL FOR A NOVEL HEMATOREGULATORY PEPTIDE, Journal of the American Chemical Society, 118(50), 1996, pp. 12862-12863
Citation: Jf. Callahan, ADDICTION MEDICINE - DEFINITION OF THE SPECIALTY THROUGH DEFINITION OF THE PRACTICE, Journal of addictive diseases, 14(2), 1995, pp. 101-107
Authors:
HOOG SS
ZHAO BG
WINBORNE E
FISHER S
GREEN DW
DESJARLAIS RL
NEWLANDER KA
CALLAHAN JF
MOORE ML
HUFFMAN WF
ABDELMEGUID SS
Citation: Ss. Hoog et al., A CHECK ON RATIONAL DRUG DESIGN - CRYSTAL-STRUCTURE OF A COMPLEX OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE WITH A NOVEL GAMMA-TURN MIMETIC INHIBITOR, Journal of medicinal chemistry, 38(17), 1995, pp. 3246-3252
Citation: Jw. Bean et al., CONFORMATIONAL STUDY OF 8-MEMBERED DIAZOCINE TURN MIMICS BY 2-DIMENSIONAL NMR-SPECTROSCOPY, FEBS letters, 354(2), 1994, pp. 143-148
Authors:
CALLAHAN JF
NEWLANDER KA
BURGESS JL
EGGLESTON DS
NICHOLS A
WONG A
HUFFMAN WF
Citation: Jf. Callahan et al., THE USE OF GAMMA-TURN MIMETICS TO DEFINE PEPTIDE SECONDARY STRUCTURE (VOL 49, PG 3479, 1993), Tetrahedron, 49(31), 1993, pp. 6741-6741
Authors:
NEWLANDER KA
CALLAHAN JF
MOORE ML
TOMASZEK TA
HUFFMAN WF
Citation: Ka. Newlander et al., A NOVEL CONSTRAINED REDUCED-AMIDE INHIBITOR OF HIV-1 PROTEASE DERIVEDFROM THE SEQUENTIAL INCORPORATION OF GAMMA-TURN MIMETICS INTO A MODELSUBSTRATE, Journal of medicinal chemistry, 36(16), 1993, pp. 2321-2331
Authors:
KU TW
ALI FE
BARTON LS
BEAN JW
BONDINELL WE
BURGESS JL
CALLAHAN JF
CALVO RR
CHEN LC
EGGLESTON DS
GLEASON JG
HUFFMAN WF
HWANG SM
JAKAS DR
KARASH CB
KEENAN RM
KOPPLE KD
MILLER WH
NEWLANDER KA
NICHOLS A
PARKER MF
PEISHOFF CE
SAMANEN JM
UZINSKAS I
VENSLAVSKY JW
Citation: Tw. Ku et al., DIRECT DESIGN OF A POTENT NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST BASED ON THE STRUCTURE AND CONFORMATION OF A HIGHLY CONSTRAINED CYCLIC RGD PEPTIDE, Journal of the American Chemical Society, 115(19), 1993, pp. 8861-8862